Mepolizumab in Nasal Polyposis

NCT01362244 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

109

Enrollment

INDUSTRY

Sponsor class

Conditions

Nasal Polyps

Interventions

DRUG: Mepolizumab
DRUG: Placebo
DRUG: Run In Medication

Sponsor

GlaxoSmithKline